Podcasts about Bausch

In this episode of the Interventional Glaucoma Podcast, Prof. Gus Gazzard is joined by Prof. Cédric Schweitzer and Dr. Marc Töteberg-Harms to explore what the data tell us about interventional glaucoma. They discuss the robustness of Elios peer-reviewed evidence on efficacy, safety, and long-term outcomes, the crucial role of high-quality data in guiding everyday clinical decisions, and the continued commitment to ongoing research and future data collection in glaucoma care.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.  ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.  Find out more about ELIOS : http://bit.ly/4lWBJZ1

Marie Gales, Lucien Czuga, Al Ginter, Jacques Kapp an den Kultregisseur an Dréibuchauteur vun 'Troublemaker' a Co iwwer d'Wochenaktualitéit

  Die Immo26 in Zürich ist DIE Immobilienmesse für professionelle Investoren, Family Offices, Pensionskassen und Vermögensverwalter. In dieser Podcast-Folge spreche ich mit Gründer Roland Vögele darüber, wie aus einer Idee eine der wichtigsten Immobilienplattformen der Schweiz geworden ist. Wir zeigen dir, warum an der Immo 26 alle Aussteller denselben Stand haben – vom Projektentwickler über Bauunternehmen bis zum Fondsanbieter – und weshalb genau das der Messe ihren besonderen Charakter gibt. Du erfährst, welche Besucher Roland sich wünscht und warum die Immo konsequent auf Professionalität setzt. Wir sprechen auch darüber, wie sich die Messe 2025 entwickelt hat, weshalb 2026 in eine grössere Halle gewechselt wird und was dich mit zusätzlichen Foren und Formaten wie der „Stage 8" erwartet. Im zweiten Teil geht es um direkte und indirekte Immobilieninvestments in der Schweiz. Roland erklärt, warum Schweizer Immobilien trotz Krisen und Unsicherheiten als sicherer Hafen gelten und weshalb 2025 ein extrem starkes Jahr für Immobilienanlagen war. Wir beleuchten, welche Renditen bei indirekten Produkten realistisch sind und wo die Risiken bei Finanzierung und steigenden Kreditmargen liegen. Ausserdem klären wir, welche Bedeutung Themen wie Regulierung, Nachhaltigkeit und die Abschaffung des Eigenmietwerts ab 2028 für Investoren wirklich haben. Am Ende weisst du genau, warum sich die Reise zur Immo 26 am 14. und 15. Januar in Zürich für dich als Profi-Investor lohnt. Die 4 wichtigsten Themen der Folge: ● Entstehung und Konzept der Immo-Messe: von 80 m² Testfläche zur führenden Immobilienmesse für Investoren in Zürich ● Fairer Auftritt für alle: gleiche Stände, tiefere Einstiegskosten und ein durchdachtes Gesamtkonzept aus Messe, Forum und Magazin ● Direkte vs. indirekte Immobilieninvestments: Chancen, Risiken, Renditeerwartungen 2025/2026 und Rolle von Pensionskassen & Family Offices ● Aktueller Schweizer Immobilienmarkt: Zinsentwicklung, Nachfrageboom, Finanzierungsmargen, Regulierung und warum Immobilien trotzdem „Safe Haven" bleiben  

Troublemaker oder lonesome Cowboy? Viru Kuerzem koum dem Andy Bausch säi Kuerzfilmprogramm "Make it Short" an de Kino, mat deem hien op eng Manéier 40 Joer Karriär am Film Revue passéiere léisst. Dat war d'Theema vum B-Radio de leschte Sonndeg. Hei en Extrait aus der Emissioun, an där de Michel Delage mam Andy Bausch a sengem Acteur a Co-Produzent Nilton Martins geschwat huet.

Ab 1. Januar 2028 wird der Eigenmietwert in der Schweiz abgeschafft – mit massiven Folgen für dich als Schweizer Eigenheimbesitzer. In dieser Folge sprechen wir mit Giuseppe Schipani Sanitärunternehmen und Mitglied GL Benz+CIE AG sowie Immobilien-Experte Christian Brunner Dozent und Inhaber SFGM darüber, wie du bis Ende 2027 noch optimal von Heizungs- und Sanierungsmassnahmen profitieren kannst. Besonders spannend: Wer gewinnt steuerlich wirklich – und wer gehört klar zu den Verlierern des neuen Systems? Ältere Eigentümer mit tiefen Hypotheken profitieren, während Erstkäufer und stark belehnte Haushalte eher ins Hintertreffen geraten. Gleichzeitig bleibt der Sanierungsbedarf riesig, denn der Gebäudebestand in der Schweiz ist überwiegend alt und vielfach energetisch überholt. Wir zeigen dir, warum du eine Heizungssanierung nicht auf den letzten Drücker in 2027 schieben solltest – Stichworte: Bewilligungen, Engpässe bei Unternehmern und Materialverfügbarkeit. Du erfährst, weshalb die Schlussrechnung für deine Heizungssanierung spätestens Ende 2027 vorliegen muss, um steuerlich noch abziehbar zu sein. Wir gehen darauf ein, welche Rolle Fördergelder, CO2-Ziele und kantonale Unterschiede spielen und warum der Ersatz der Wärmeerzeugung meist der wichtigste Hebel ist. Und wir besprechen, wie ein durchdachtes Sanierungskonzept deinen späteren Verkaufspreis positiv beeinflussen kann. Wenn du dein Eigenheim besitzt oder in den nächsten Jahren kaufen willst, ist diese Folge Pflichtprogramm. Die 4 wichtigsten Themen der Folge: ● Abschaffung Eigenmietwert & Steuerfolgen Wer profitiert vom neuen Regime (v. a. 65+ mit tiefer Belehnung) und wer verliert (Erstkäufer, hoch belehnte Eigentümer, Schuldzinsabzug bei Unternehmenskäufen). ● Timing der Heizungssanierung bis Ende 2027Warum die Schlussrechnung bis 31.12.2027 vorliegen muss, welche Planungs- und Bewilligungszeiten du einkalkulieren solltest und weshalb ein "Sanierungs-Peak" 2027 zu Engpässen führen kann. ● Fördergelder, CO2-Ziele und energetische Sanierungen Fossile Heizungen als CO2-Treiber, hohe Förderbeiträge (z. B. Stadt Zürich), Diskussion um zukünftige Förderlogik und die Bedeutung von energetischen Massnahmen als steuerlich werterhaltend. ● Strategisches Vorgehen für Eigentümer Ganzheitliche Betrachtung des Gebäudes (Heizung, Hülle, Fenster, Bäder), Instrumente wie GEAK Plus, Zusammenarbeit mit Fachbetrieben und der Einfluss des Gebäudezustands auf den späteren Verkaufspreis.

Dëse Sonndeg ass en neien Episod vum B-Radio programméiert, an zwar mam Andy Bausch. Ufanks den 90er huet de Lëtzebuerger Realisateur méi wéi eng Kéier mam däitschen Acteur Udo Kier zesummegeschafft, dee viru Kuerzem gestuerwen ass. Hei scho mol e Virgeschmaach op de B-Radio.

Fenstermontage ist oft Schwerstarbeit - und birgt Risiken für Rücken und Gelenke. Dabei wäre vieles vermeidbar: mit cleverer Planung, guter Baustellenlogistik und den richtigen Hilfsmitteln. In dieser Folge erfährst du, wie sich Rückenschmerzen, Verzögerungen und Zusatzkosten vermeiden lassen - und wie Planer, Bauleiter und Bauherren konkret davon profitieren. Ideal für alle, die Fenster effizient, sicher und körperschonend einbauen wollen. Unsere Experten im Gespräch: Jonathan Barwig, Projektleiter Fenster bei 1a hunkeler fenster AG sowie Andreas Bachmann, Gründer der Bachmann Montagen GmbH Darum geht's in dieser Folge: • Was bei Planung und Ausschreibung oft vergessen geht - und teuer wird • Wie eine gute vorbereitete Baustelle Wartezeiten verhindert • Welche Hilfsmittel sinnvoll sind - und wie sie richtig eingesetzt werden • Warum Podeste, Gerüsthöhen und Zufahrten matchentscheidend sind Mehr zum Thema: www.suva.ch/optibau Weitere Podcastfolgen und Blogartikel findest du unter: www.marcofehr.ch/mehr Abonniere, sonst gibt's Bauschäden ╔═╦╗╔╦╗╔═╦═╦╦╦╦╗╔═╗ ║╚╣║║║╚╣╚╣╔╣╔╣║╚╣═╣ ╠╗║╚╝║║╠╗║╚╣║║║║║═╣ ╚═╩══╩═╩═╩═╩╝╚╩═╩═╝ Für weitere Fragen kontaktiere bitte diese Adresse: redaktion@marcofehr.ch --------------------------------------------------------------- Folge mir auf diesen Kanälen für mehr Bauqualität und Kosteneinsparung • LinkedIn - https://www.linkedin.com/in/marco-fehr/ • Facebook - https://www.facebook.com/marco.fehr.12 • Twitter - https://twitter.com/MarcoFehr_ • Tiktok - https://www.tiktok.com/@bauherren_podcastschweiz • Instagram - https://www.instagram.com/marco.fehr_/ • Blog - https://marcofehr.ch/baublog/ • Spotify - https://open.spotify.com/show/2XPzukLLm2EGVxpVwMoiys • YouTube - https://www.youtube.com/@bauherrenpodcastschweiz • iTunes - https://podcasts.apple.com/ch/podcast/bauherren-podcast-schweiz/id1485359745 • LinkedIn Bauexperten Gruppe - https://www.linkedin.com/groups/13832518/ • Marketing-Akademie für Bauexperten - https://baufachwissen-akademie.ch/course/baufachwissen-marketing

In this episode of the Interventional Glaucoma Podcast, Prof. Gus Gazzard speaks with Dr. Marc Töteberg-Harms and Dr. Timothy Hamann about the health economics of interventional glaucoma. They discuss how MIGS can deliver long-term savings and quality-of-life benefits despite higher upfront costs, highlight evidence supporting its cost-effectiveness, and emphasize the growing ethical responsibility for clinicians to discuss MIGS options with eligible cataract patients.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.  ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.  Find out more about ELIOS : http://bit.ly/4lWBJZ1

En Aktiounsplang géint Rassissmus, deen ze spéit kënnt, dem François Bausch seng nei Aufgab an d'Lokalpolice, déi net alles kann, dat sinn d'Theemen haut an der Presserevue.

Neste episódio do Canary Cast, Kristian Huber, General Partner do Canary, conversa com Mariano García, Founder e CEO da Axenya, empresa que está transformando como as empresas brasileiras gerenciam a saúde de seus colaboradores por meio de dados, tecnologia e um modelo de negócio alinhado aos interesses de todos os atores da cadeia. A Axenya nasceu de uma tese simples, mas poderosa: o mercado de saúde precisa ser atualizado, e não há melhor momento para iniciar essa mudança do que agora. Criado em 1935 para lidar principalmente com doenças agudas (curta duração e alta intensidade), o sistema de saúde sofre hoje com mais de 85% dos custos relacionados a doenças crônicas — um volume para o qual ele não foi desenhado e que acaba desequilibrando as contas de diversos elos da cadeia, recaindo principalmente sobre os pagadores. Enquanto a tecnologia médica avançou significativamente no tratamento de doenças agudas, a expectativa de vida aumentou, a ocorrência de doenças crônicas se estendeu ao longo da vida e o sistema não se adaptou para acompanhar necessidades como monitoramento contínuo, prevenção e intervenção no momento certo. O resultado? Hoje, aproximadamente 50% dos custos de saúde estão relacionados a ineficiências de monitoramento e falta de ação preventiva — não ao volume de atendimentos, medicamentos ou procedimentos médicos em si. A solução que Mariano desenvolveu com a Axenya, apoiado em seus muitos anos na indústria de saúde, foi construir uma plataforma de gestão que agrega dados de múltiplas fontes (wearables, registros médicos, comportamento), os processa em tempo real e identifica populações em risco para intervir antes que doenças se agravem. Hoje, com uma população de 100 mil vidas sob monitoramento, a Axenya realiza mais de 95 milhões de análises clínicas por mês — um volume que seria impossível de executar mesmo se todos os médicos do Brasil trabalhassem exclusivamente para a empresa. No episódio, Mariano compartilha sua trajetória de 25 anos no setor de saúde — passando por Pfizer, Warburg Pincus, Bausch, Empresas de Biotecnologia e Advent — e como essa experiência o levou a identificar a oportunidade de reinventar a forma como empresas compram e gerenciam planos de saúde. Ele explora os principais desafios do mercado, como o desalinhamento de incentivos entre corretoras, planos e pacientes, e como a Axenya está rompendo esse ciclo ao se remunerar apenas pelo valor que entrega — e não pela comissão sobre o que é gasto.Destaques do episódio: 00:00 – 02:20 Introdução do episódio e apresentação do convidado02:28 – 07:20 Trajetória de Mariano Garcia no setor de saúde: de Pfizer a empreendedor07:22 – 09:40 O início da tese da Axenya a partir da ascensão do volume de dados em saúde09:44 – 14:35 As dores do setor de saúde: quais são os principais vetores de custo e o desalinhamento de incentivos14:35 – 17:33 Por que empreender com saúde no Brasil especificamente17:33 – 19:11 O que Mariano aprendeu como investidor, executivo e empreendedor que leva para a Axenya19:23 – 21:30 Complexidade de dados e os pontos de inflexão que permitem a solução da Axenya existir21:37 – 24:50 Proposta de valor da Axenya: como entrega valor para cada elo da cadeia (empresa, plano, paciente)25:00 – 27:00 O paradoxo da Axenya: mais consultas e exames, mas 50% menos de custos28:00 – 31:25 Quem é o cliente Axenya hoje e como quebra a resistência do mercado tradicional31:27 – 32:13 Modelo de negócio: monetização por success-fee em vez de comissão32:14 – 34:54 Quebrando a dinâmica anual de troca de planos: modelos de alinhamento de incentivos34:55 – 38:12 Os impactos da Axenya: redução de sinistralidade, eficiência de custos e NPS de 95+38:13 – 41:40 A visão de futuro: de otimizador de planos para plataforma completa de gestão de saúde41:42 – 44:30 Maiores erros, acertos e aprendizados sobre times e cultura44:48 – 47:10 A importância de pensar diferente do mercado: first principles vs. playbook47:16 – 48:19 Conselho para o Mariano do passado48:30 – 50:50 Conteúdos recomendados51:00 – 51:49 Conclusão do episódioConteúdos recomendados no episódio:"Redefining Healthcare: Creating Value-Based Competition on Results" de Michael Porter Livro seminal que introduziu o conceito de value-based healthcare há mais de 20 anos."Software is eating the world, yet healthcare remains INEDIBLE: How to Build the Modern, Tech-Enabled, Healthcare Experience" de Mariano García ValiñoMariano destaca que Porter escreveu sobre saúde baseada em valor de forma teórica, mas hoje, com as ferramentas tecnológicas disponíveis (como as que a Axenya usa), é possível colocar essas ideias em prática. É quase uma homenagem a Michael Porter, mas com a tecnologia que ele não tinha à época. "The Innovator's Prescription: A Disruptive Solution for Health Care" de Clayton Christensen Do mesmo autor que criou o conceito de "disrupção" e escreveu "The Innovator's Dilemma", este livro explora como inovação pode resolver os problemas estruturais da saúde. Apesar de ter cerca de 15 anos, mantém sua relevância e é essencial para entender dinâmicas de inovação em saúde. "The Cold Start Problem: Using Network Effects to Build Great Products" de Andrew Chen Livro focado em como construir marketplaces e ativar network effects. Essencial para quem está construindo plataformas que dependem de múltiplos atores (empresas, planos, pacientes, provedores) e precisa entender a dinâmica de como fazer todos os lados funcionarem simultaneamente. Glossário de termos mencionados ao longo do episódio: Doenças Crônicas — Condições de saúde de longa duração (diabetes, hipertensão, obesidade, doenças cardiovasculares) que exigem monitoramento contínuo e não têm cura, apenas controle. Doenças Agudas — Condições de saúde de curta duração e alta intensidade (infecções, fraturas) para as quais o sistema de saúde foi originalmente desenhado em 1935-1940. Sinistralidade — Percentual do prêmio de seguro que é gasto efetivamente em saúde. Exemplo: 75% de sinistralidade significa que de cada 100 reais em prêmio, 75 são gastos com saúde. Wearables — Dispositivos (smartwatches, pulseiras) que coletam dados de saúde em tempo real, como frequência cardíaca, passos, sono, etc. Monitoramento Remoto — Acompanhamento contínuo da saúde de pacientes sem necessidade de presença física, usando tecnologia e dados. Lead Qualification / Qualificação de Leads — Identificar e priorizar pacientes em risco que precisam de intervenção preventiva. NPS (Net Promoter Score) — Métrica que mede a satisfação e lealdade do cliente, variando de -100 a +100. B2B (Business-to-Business) — Modelo de negócio entre empresas. No caso da Axenya, vende para empresa → plano de saúde → paciente. Corretora de Seguros — Intermediária tradicional que vende planos de saúde para empresas, geralmente cobrando comissão sobre o valor do plano. Success-Fee — Modelo de remuneração baseado em resultados: a empresa paga apenas pela economia ou valor entregue, não por comissão fixa. Inflação Médica — Crescimento dos custos de saúde que é 2,5x maior que a inflação geral da economia. Modelo de Negócio Alinhado — Quando os incentivos financeiros de todos os atores (empresa, plano, paciente, provedor) apontam para o mesmo objetivo: melhor saúde com menor custo. Fragmentação de Dados — Situação em que dados de saúde estão espalhados em múltiplos sistemas sem integração, dificultando análises e ações. Interoperabilidade — Capacidade de diferentes sistemas e fontes de dados se comunicarem e compartilharem informações. Algoritmos Preditivos — Modelos matemáticos que usam dados históricos para prever eventos futuros, como o risco de um paciente desenvolver diabetes. Processamento de Dados em Tempo Real — Análise e ação sobre dados conforme são gerados, não em lotes posteriores. Aderência (Medicamentosa) — Capacidade do paciente de seguir corretamente o tratamento prescrito (tomar medicamentos no horário, na dose correta). Estatinas — Classe de medicamentos usados para controlar colesterol, uma das prescrições mais comuns no mercado. Retinopatia — Complicação da diabetes que afeta a visão e pode levar à cegueira se não controlada. First Principles — Abordagem de resolução de problemas que volta aos fundamentos básicos em vez de seguir convenções ou playbooks estabelecidos. Playbook — Conjunto de estratégias e processos padronizados que o mercado segue tradicionalmente. IPO (Initial Public Offering) — Oferta pública inicial; quando uma empresa abre seu capital na bolsa de valores. Private Equity — Modelo de investimento onde fundos adquirem empresas privadas para operá-las e depois vendê-las com lucro. Venture Capital — Tipo de investimento focado em startups de alto potencial de crescimento.See omnystudio.com/listener for privacy information.

Nesse bate-papo, as doutoras Maria Auxiliadora Frazão e Elisabeth Guimarães abordam os principais aspectos relacionados ao uso das lentes de contato.Desde as diversas variações na prática médica até dicas de uso, armazenamento e higienização para os pacientes, este podcast traz informações úteis tanto para médicos especialistas quanto para quem utiliza lentes de contato.Assista, comente o que achou do conteúdo e compartilhe!

Sophie Charlotte Kirk, Daniel Bausch und new Talents über Mentoring, künstlerische Identität und neue Wege im Förderprogramm New Talents Ruhr – im Kunstpodcast Die Leichtigkeit der Kunst.

In this episode of the Interventional Glaucoma podcast, Prof. Gus Gazzard speaks with Dr. Neeru Vallabh and Mr. Dirk Mühlhoff about how excimer laser technology is transforming glaucoma treatment. They discuss Excimer Laser Trabeculostomy (ELT), which uses ultraviolet light to create precise, non-thermal microchannels in the trabecular meshwork, improving natural fluid outflow. The conversation highlights how this laser, long used in refractive surgery, is now offering a safe, minimally invasive option for glaucoma patients.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.  ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.  Find out more about ELIOS : http://bit.ly/4lWBJZ1

Sarah Ptach, President and CEO of Canyon Labs, discusses her journey from professional sports and advertising to leading Canyon Labs, a company specializing in medical device and pharmaceutical testing. Inspired by her father's Parkinson's diagnosis, Sarah transitioned to healthcare to make a meaningful impact. She delves into her leadership philosophy, emphasizing the importance of trust, transparency, and collaboration in building a strong company culture. Sarah also highlights Canyon Labs' dedication to elevating industry standards and ensuring patient safety.    Guest links: https://canyonlabs.com/ | https://www.linkedin.com/in/sarahptach/  Charity supported: The Michael J. Fox Foundation for Parkinson's Research Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 067: Sarah Ptach [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I am super excited to introduce you to my guest, Sarah Ptach. Sarah is the President and CEO of Canyon Labs, a leading provider of medical device and pharmaceutical testing, consulting, and sterilization services. She joined the company during a critical ownership transition with a clear goal in mind: to raise the standard of service in the industry and build a true end-to-end solutions partner. Drawing on her background in packaging engineering and testing, Sarah focused on expanding beyond packaging alone to create a more integrated, accessible, and expert driven experience for clients. Sarah began her career in professional sports and advertising, but a desire to create more meaningful impact led her to the healthcare space after her father was diagnosed with Parkinson's disease. She went on to help grow and successfully exit a packaging firm before bringing her vision and leadership to Canyon Labs. In addition to her role at Canyon, she co-leads Kilmer Innovations and serves on the board of the Medical Device Packaging Technical Committee of the Institute of Packaging Professionals. She remains deeply committed to advancing healthcare through innovation, expertise, and strong partnerships. All right. Well, thank you so much for being here, Sarah. I'm so excited to welcome you to the show. [00:02:05] Sarah Ptach: Likewise. Thank you, Lindsey. I appreciate you having me. [00:02:08] Lindsey Dinneen: Of course. Well, I'd love if you would start off by telling us just a little bit about yourself, your background, and what led you to MedTech. [00:02:16] Sarah Ptach: Yeah. Thank you. So I'm Sarah Ptach. I'm the president of Canyon Labs. I have kind of an interesting story of getting into to medtech. I originally started my career actually in professional baseball. I was a contract negotiation person mainly for closing pitchers. And I ran track in college. I thought like, "oh, I wanna be in sports." And I like to say that's the most fun I never wanna have again. It was, it was a great start of a career. It teaches you a lot about negotiation, teaches you a lot about high stakes opportunities. But, you know, in the end it, it felt very kind of un unfulfilling in that perspective. And so I had kind of then taken that into to marketing for a pretty big ad agency in Chicago and hit the same thing. I felt like I was-- you know, now I was just selling people stuff that they didn't need instead of promoting people that, you know, that make a ton of money in the sports industry. And at the time my dad was diagnosed with Parkinson's disease and I wanted to feel like I was making a difference. So I, I went back and got my MBA and my whole goal of that was really to, to use my skills to, to do something that makes a difference in people's lives. So, I had reached out to a really small medical device company and it's " I'm willing to make no money as long as we, we have a difference in a change we can make in the world." And at the time that company couldn't hire me but I ended up getting introduced to another company through that that was in medical device packaging validation. And that was the first dip of medical device that I had. And that company's Packaging Compliance Labs. I was one of the first employees there and we grew that company until it sold a couple years ago. And through that, learned a ton about the medical device space. I kind of made it my personal mission beyond just my job to, to go try to participate in the industry as much as possible, push the status quo of things as much as possible, and really kind of learn where the testing realm or validation realm can make a difference in, in medical devices. And so after that, I was given the opportunity to step in and run and grow Canyon Labs. And Canyon is a whole platform. So for me, it was taking the packaging knowledge that, that I love so much and making that a full service offering. You know, I had always dabbled in sterilization or heard about Biocom, but never really gotten my hands on it. And to be able to be that full service solution with Canyon has not only been a awesome offering to, to give to our clients to really be able to go A to Z, everything from your regulatory to your microbiology, chemistry, packaging, bio comp, and toxicology. But also a good learning challenge for me. I thought that I was, you know, a pretty good packaging engineer and now learning chemistry and microbiology and toxicology, I'm like, "oh, wow. I'm definitely not as smart as I maybe thought I was originally," and I luckily have some amazingly intelligent individuals that, that work on our team, but it's, it's an awesome opportunity to, to not only get to help bring some life-changing medical solutions to market but also have a really good technical brain challenge every single day. [00:05:26] Lindsey Dinneen: Wow. Oh my goodness. I love that. And yes, I mean, sometimes I feel like actually, you know, not being the smartest person in the room is such a gift because then you get to talk to all these really cool people with really amazing experiences and learn. And I'm just one of those people who's constantly-- well, I'm curious all the time, so if I don't understand something, I'm like, "can you tell me more?" [00:05:48] Sarah Ptach: Yeah. No I love that. I completely agree. I think that the better that you can be at facilitating conversations, the, you know, the more successful your organization will be. And it, I really think as the leader of a company it's less about being the, you know, smartest person in the room and more about being the facilitator of that collaboration. [00:06:10] Lindsey Dinneen: Yeah. Yeah, absolutely. I love that. So, okay, so going back in time a little bit-- so, so I know you started off with professional sports, which is really cool. Like what a, what an interesting, unique opportunity and experience and you know, you'll maybe never want that particular brand of fun again, but. I still love that you got to do it. And so I'm curious though, was that always the sort of planning goal for you? Or when you were trying to think about career paths and all of that, younger, what were you envisioning? [00:06:39] Sarah Ptach: Yeah. I think I, I always envisioned myself as a leader. The packaging side of things became my kind of technical passion. But I mean, from a young age, I've always been the captain of the track team or the, you know, the head of any school organization I was a part of. So I always knew I, I wanted to be a leader. I think now, you know, being in that role, you, you learn so much about what different styles and brands of leadership is. I think, you know, to go back to your question about being the smartest in the room, I actually think that, you know, the CEO's job isn't to have all the answers. It's to create the culture where the answers emerge. And, you know, I've always wanted to be a leader. I've been passionate on that side, but I really think that the more, you know, more so than just having leadership pieces to you. It's about having that power to bring people together in that way. [00:07:31] Lindsey Dinneen: Yeah. That's a beautiful way to put it. And I actually would love to dive into this more because I know creating a really positive, good company culture is really important to you, and it's frankly, easy to get wrong, unintentionally-- sometimes maybe it just is what it is, but like sometimes it's not a desire to create it, but it happens. So I'm curious, how have you really intentionally cultivated your current company culture, and where did those lessons come from? [00:08:00] Sarah Ptach: Yeah. Deep question. You could answer that in a bunch of different ways and I could talk your ear off about lessons learned on that side. But I, I think the, you know, the most overlooked competitive advantage, both internally and externally is trust. Like the trust in your team to make decisions, the trust in your clients and even the FDA and your labs work. There's trust across it all. I think internally, from culture standpoint, it's have that trust in people and build, you know, people in a way that, that helps them feel most confident to, to make the decisions that they need to succeed. You know, when we first started talking you, you asked if I have any kind of lesson learned stories and some, I dunno, harsh realities per se. I think one of the more difficult kind of lessons that, that I learned in the course of just being a leader, is knowing when you have a passion for someone and what passions they might have. And I stayed that in the standpoint that I'm a huge believer in people. I want them to be like the greatest version of themselves, and I want them to dream big and go big and, you know, sometimes that's not always what people want for themselves too. And it's, it's a tough reality somewhat to to come to at times. But, you know, really finding what is the growth that people truly want. What is the environment that they want to live in, and how do you help foster something that, that meets the plethora of those ideals that you'll have across an organization is really important. But I think the, the culture I've worked really hard to foster at Canyon and frankly, my, my team fosters alongside me every day. This is by no means just a Sarah show on that piece. But it's a culture of trust, like I said, and it's a culture of transparency. I always like to tell my team, "you know, when I ask questions or probe I'm not trying to get an answer or I'm not trying to, you know, question your way of thinking. I'm trying to understand so that I can be at the same table that you're at and we're not, you know, talking oranges and apples and not realizing it." And so I really try to make sure we foster an environment where there's collaboration, there's trust to have that collaboration. There's trust to have challenges made of each other without it being an inflection of, you know, disliking someone. And then creating that opportunity to ask questions and always stay inquisitive in a way that's meant to greater raise everyone up together. [00:10:28] Lindsey Dinneen: Yeah, that's a wonderful culture that you're cultivating and I love that. But I think you hit on something really key amongst all of the really great points you made, but one of them that really stood out to me was, you talked about how it's not just the Sarah show in this way. It's a whole group effort. And I think that is a critical component that sometimes is forgotten. Like we sometimes think, you know, it's the leader's sort of job or role or just is. It is their leadership. That sort of filters down into the rest of the company and we think it's like a top down way of doing culture, but culture is about absolutely everybody involved in the company. So I'm curious, how do you empower your team members or, and, or when a new team member comes in, how do you communicate, "Hey, this is who we are, these are our values," and make sure that it is a good cultural fit too. [00:11:23] Sarah Ptach: Yeah. You know, we really at Canyon do a lot of things that are just small to, to reinforce and drive culture. We have these bracelets that you can earn, and what they mean is they're all of our company values and you can honor a fellow coworker for, for going above and beyond, or embodying teamwork or really showing integrity. And they get that read out in front of their whole department, and then they get a bracelet to wear proudly. So we do little things to to enhance our culture. And then there's the more macro level pieces, and I think having a baseline understanding of why we all show up to work every single day. You know, it really is to empower life changing medical innovation, and it's to ensure that all the products on the market are not gonna hurt somebody and they are going to, you know, do what they're meant to do in a positive way. You know, if we can all show up with the basis of "everything I do every day is for patient safety," then I think the getting on board with the culture is a lot easier if we all have that base, like regardless of how your day goes, regardless of your email inbox going crazy, we all agree that, you know, patient safety is what we're here to do. And you know, how we can have fun along the way, support each other, do teamwork is just gravy on top of that. So I'd say it's starting with culture that gets that base level item. And once you get that, everything else is just working better together. [00:12:48] Lindsey Dinneen: Yeah. Yes. And honestly, that's a great segue to my next question, but I was really-- I think you, again, honed in on something really critical and having everybody around a shared mission is so cool because that passion and that excitement and that " we're all in this together" and when disagreements or issues come up, which --we're human, they do-- then you can always go back to that shared mission and values of the work we're doing matters. We are all on the same side to provide value to our clients to ensure safety for our patients. So, I think that's a really key thing that you touched on there. Yeah. [00:13:33] Sarah Ptach: Don't get me wrong. I mean, it's a difficult thing to, you know, to keep going on teams. We, Canyon, we did two acquisitions this year. And with that comes a lot of combining cultures, changing culture together, all getting on the same page. And it's not easy, bumps along the road, you know, I think showing that we're all on the same page and working and rowing in the same direction is a conversation I have every single week. And so it's something you can keep reinforcing. And I think it's stacking bricks. You don't just have a house, you gotta continually stack bricks on it. And everyone needs to be involved in saying, "yeah, I wanna be a part of this team and I wanna be a part of this shared mission." And it doesn't build itself overnight. [00:14:19] Lindsey Dinneen: Yeah, absolutely. So speaking and then mentioning back to that segue, 'cause I just didn't ask the question, but can you share more about Canyon Labs and the incredible work that your company is doing for this industry? [00:14:34] Sarah Ptach: Yeah. Yeah. So like I said we're a full service contract testing and consulting firm within the medical device and pharmaceutical space. You know, a lot of the work we're doing is to help a lot of medical devices and drugs in their validation stage. So, you know, we're working through anything from, you know, designing your package to helping your sterilization strategy. You know, sterilization has been something I talked to, I've spoken on a lot this year. You know, it's a hot topic item in the industry. It's something that a lot of people are dealing with 'cause it has EPA implications as well as now tariffs affecting it as well as supply chain issues within it. So I'd say that's a division I talk to a lot and we help a lot of people navigate those. But the underlying whole piece of Canyon is being that trusted lab partner and we're really trying to raise the standard of service in this industry. You know, I came into Canyon being on the other side of the table and sending samples off to get biocom tested or to go through their sterilization validation. And, you know, for me it was this baby I was sending off to be tested and I don't think I was always met with the best customer service or the best accessible expertise when I needed it. And so we, when we built Canyon, we really built it to, to change that. You know, I want our clients to feel like we're one phone call away for any question that they have. You know, we're not just gonna send them their samples back, say, "sorry, it failed. Let us know when you're ready to give us another PO." That, that transactional relationship is, it's a currency that I don't wanna participate in. And so we really saw it after changing that in the industry. [00:16:16] Lindsey Dinneen: Yeah. Excellent. Well, yeah and I love the fact that you were on that flip side and it could bring such a valuable perspective to the company and go, "okay, here's some lessons learned." You know, and you're always gonna get a mix of it, right? You're gonna get like, "Ooh, I don't know if this is how it should be or needs to be," and you're gonna go, "oh, but here's something that they did excellently." So to bring that very valuable perspective is really cool. [00:16:40] Sarah Ptach: Yeah it's been fun. It's you know, in Canyon's infancy a couple years ago, we had the opportunity to come together with a lot of people from different experiences on our leadership team, and so it's-- as long as we all have the baseline humility to say "the way I did it in the past is not necessarily correct," you know, we could all come together and say, "here's what I did, here's what I did, here's what I did. Okay, let's pick the best of all worlds." So it it was a cool opportunity to have a lot of people with a lot of past experience come to a table that was completely, even in that standpoint. [00:17:18] Lindsey Dinneen: Yeah. Excellent. So I know that you are-- well, okay, so I took a look at your LinkedIn profile and had a wonderful time learning a little bit more about you, but I know you are involved so much. Like you are just, I don't know if you sleep because... [00:17:35] Sarah Ptach: Sometimes. [00:17:36] Lindsey Dinneen: Yeah. But the, I especially noticed, you know, you're a founding board member for thePACKout and you've done you're involved in a lot of different boards and groups and you're, it seems like you're just, you know, volunteering as kind of your heart and soul and serving in that way. And so I was wondering if you could speak a little bit about those opportunities that you're with too. [00:17:55] Sarah Ptach: Yeah. I think, first and foremost, before any job or role or position I've ever held, I am baseline, a huge proponent of this industry. And, you know, going back to my original reason to be here, it was my dad having Parkinson's and Parkinson's doesn't have a lot of treatment at this point. And it was like, I hate that. So how do I participate in solving that? And I think being involved in the industry, the super cool part, especially about packaging, is there's so much room for improvement at this point. You know, a lot of the standards that we function off of, they are being improved on a yearly basis, but they weren't made that long ago. So the, you know, the baseline ground zero is not that long ago. And I mean, there's people in the industry that are still in the industry that were there when they made ISO 11607. So it's, you know, it's, it's got a lot of room for improvement. I love how much the industry is trying to go back to patients now, and, you know, we're not just trying to design packages or devices that work well for, you know, me, the manufacturer, or me, the physician, but instead it, you know, really does consider patient comfort, patient safety. So the, a lot of what you'll see of my involvement in the industry is related to patient facing parts of of standards. I'm part of the Kilmer Renovations and Packaging Group and specifically I lead the aseptic presentation group, which is meant to evaluate the way that healthcare technicians interact with packaging in a way to help reduce hospital acquired infections. You know, we used to only design packages as an engineer because it's the perfectly engineered package. And, you know, we didn't think about the nurse that's trying to open it and your perfectly engineered package is just way too hard for a nurse to open and the device goes flying across the room. So it you know, we, we weren't considering those things. So our group is trying to correlate opening methods with types of packages and designs of packages. And we're trying to prove that with the different opening techniques that they teach in school for your surgical techs, your nurses, what is the best way for these different packages so that we can make that training and that design fit in the best way possible for positive patient outcomes. So, it's, a lot of my industry involvement is passion based, but I'd also say that a lot of the industry problems they, they can't be solved by just one company and they can't be solved in a silo. So, you know, the only opportunity you get to get all these stakeholders at the same table are these industry groups. And it's unique, I think, to the medical device industry in general that a lot of us care beyond our day jobs. You know, it's like, "cool, this is my day job, but I genuinely, passionately care about the development of my industry. And so I'm willing to, you know, volunteer my personal time." And I see that across the board every day. And it's really cool. I mean, you have people who have huge jobs at, you know, Johnson and Bausch & Lomb and Medtronic, and they're, you know, they're still willing to put their personal time on the table to advance the industry. So, yeah, all my industry involvement's pretty passion based, but it's the medical device industry and medtech industry is one that's super unique. A lot of people feel that personal passion. [00:21:20] Lindsey Dinneen: Yeah, I couldn't agree more. And thank you for sharing a little bit more about your involvement and your passion for the industry. And I feel so similarly, I, you know, when I joined the industry now a few years ago, I remember having this just moment of getting to meet all these super cool, intelligent innovators that are just literally changing the world and thinking "how lucky am I to be here and play a small part in this big changing thing," and then getting to see exactly to your point, how passionate the people are in the industry and how it's not just a job, it's like a calling. [00:21:59] Sarah Ptach: Well, I think the difference is, you know, in, in medtech, the origin or margin for error is not just financial, it's human. So where you have, you know, maybe your traditional job, you know, the margin of error is a financial impact. You know, the margin of error for people in our industry is human impacts, and that can be positive and negative. So it's hopefully the passion to make those more positively. So. [00:22:24] Lindsey Dinneen: Yes, indeed. Yeah, so, you know, I love the impact your company is making and the industry itself, like you said, is just such a cool place to be, and I think it really does invite those kinds of passionate people who are willing to just kind of be evangelists in a way for the rest of the industry in some fashion and really moving things forward. But because of the impact that's made, I'm wondering are there any moments that really stand out to you as affirming that, "hey, I am in the right place at the right time, in the right industry." [00:22:57] Sarah Ptach: Yeah. I mean, I definitely have some stories where you've-- without disclosing the details of a client-- but you know, you've been part of a launch that you watched that device go change the industry. I was a part of a company that was launching a, it's basically a, an organ transplant way of improving on how organs make it from, you know, the donor to the recipient. And it has improved patient outcomes tenfold to what they used to be. It's made it so that you could take, say, subpar lungs that used to not be able to be donated. And because of this technology, now it can, 'cause it, it has a way of it staying more intact while being transported. And you know, you get involved in those projects and, you know, you might just be helping at a small portion of it, like the sterilization or the packaging or just the biocom testing. But, you know, you watch the outcomes of that and it's like, "wow. Like I, I did that." You know, I've talked to people that work in consumer product goods and, you know, their Super Bowl is seeing their package on the grocery store aisle. And, you know, my, my Super Bowl is seeing the product that you played a part in, reach the market and change the world. Like that's, it's so cool. And to your point before you, you get to be in the room with such cool, innovative, smart people that came up with that product. I am, I'm honored to be the lab testing that is that silent backbone of medical innovation. But to be, you know, that trusted partner to, to get them to the finish line is a, it's a unique feeling, but it's really cool when you get to see a product that you played part of either touch a family member. I've been in an operating room before where I was the one being operated on 'cause I tore my ACL or did something and all I'm doing is looking at all the packaging, like, "Ooh, I did that. I tested that." Such a cool experience. It's sometimes it can be concerning 'cause you're sitting there while your doctor's trying to tell you to just get ready for surgery and you're staring at all the packaging. But it's, it's an awesome round to be in. [00:25:02] Lindsey Dinneen: Oh my goodness. I love that story so much. Yes. I mean, I could see that I, and I've talked to other folks who have similar experiences where they're, you know, they're kind of going along, something happens, they end up needing medical attention, or a family member does, and they go into the, to the hospital and they're like, "oh. I worked on that device" or "Oh, I did the cybersecurity for this one" or whatever, and just like how cool of a just full circle moment is that, and getting to watch in real time and in real life the impact that your work does. That is a huge honor and gift. [00:25:34] Sarah Ptach: Yeah, I I really did tear my ACL and my, and I also broke my back at one point in time, but my back surgeon and I have a really cool relationship and I think it's half because I was probably the biggest pain in the butt patient, 'cause leading up to that surgery it was like, "what device is it? What's the sterilization modality? Tell me what testing they did on it." And I got very lucky. My, my surgeon, his name's Dr. Michael Glisi, he has played actually a big role in getting some better improved medical devices to market both with Globus and with Arthrex. And now he plays a role in training other surgeons on how to best use those medical devices and technology. But it was such a unique relationship to get with him 'cause he's uniquely involved in the industry. So I think he, he maybe tolerates my 9 billion questions better than the average surgeon that just wants to operate on you and see you off. But it was a cool experience to get to, to have that relationship with him now after surgery and watch the impact that, that he's making on the industry as a surgeon too. So I think all stakeholders in this industry hold different areas of importance too. [00:26:49] Lindsey Dinneen: Yeah, absolutely. Oh my goodness. Yes. And, yeah, I could talk about all of this for days and I'm loving this conversation, but I am gonna pivot it, just for fun. Imagine that you were to be offered a million dollars to teach a masterclass on anything you want, could be within your industry, but it doesn't have to be at all. What would you choose to teach? [00:27:13] Sarah Ptach: Ooh, that's a good question. I do think I would teach it on people leadership. You know, I, i've been in a lot of different roles and scenarios of people, leadership, especially through acquisitions, seeing, you know, the good, bad and ugly of what other folks do. And I've been really fortunate to have a lot of different mentors in my career that took very different leadership strategies. And I'm by no means saying that I'm the perfect people leader, but I think-- I can tell you a lot of different options and why they do and don't work. So if I was to teach a masterclass it'd probably be in that and I'd be heavy on the transparent leadership side. I'd be heavy on fostering a culture of people that are comfortable talking about issues. And it's not a easy thing to balance, I think with also driving, you know, the work product of the business and the financial success of the business. But being able to marry that, to marry, you know, having a great people culture and having, you know, people that, that love being a part of your company. It, to me, it is the most important part of actually driving your financial success of your company too. And I don't think a lot of people correlate that. You know, they think "I'm the ultimate financial driven CEO. I am the gross margin king." And, you know, " I'm driving my shareholder value." But I really think that, while all that is important, it starts with the people and the more you can get people to care about what they're doing beyond just their job, the more that the natural effect is improved gross margin and better financials. So the masterclass I'd probably teach is how to combine positive people, environment, and culture with good company financial success. [00:29:07] Lindsey Dinneen: Ooh, okay. That's a very powerful masterclass I wanna go take so, so sign me up for that, for sure. That's incredible. Yeah. And you have so much advice and insight and I could just tell, like, again, we could probably talk about this for hours and be very happy, so, yeah, I love that. Okay, and then how do you wish to be remembered after you leave this world? [00:29:30] Sarah Ptach: Yeah. Someone that, that cared deeply about the industry and was willing to to give it my all. You know, you, you jokingly said, "when do you sleep?" I'd argue not a lot, but it's because I love it. Like it's 'cause I love what I'm doing and if that means I'm gonna sacrifice some sleep to make sure the thePACKout is an awesome conference or the, you know, KIPP aseptic presentation team has what we need to change a standard or Canyon, you know, do something better and greater, I'll do it all day long. So yeah, I'd like to be remembered as, at the end of the day, she just really cared. And she was in it 110% at all times. [00:30:12] Lindsey Dinneen: I love that. That's a beautiful legacy. Yes, absolutely. Okay, and then final question, what is one thing that makes you smile every time you see or think about it? [00:30:23] Sarah Ptach: Oh, I love that one. I think someone realizing that the solution to the problem that they came up with was truly right and the solution. And it's like you worked through it yourself. You made it through maybe the hard parts of that decision making, but then you executed and hot dang, it worked. Like that is such a cool experience, especially when it's someone's first time ever having like the leadership role of solving a problem or, you know, the project manager role of solving that problem. It's super cool 'cause you get to watch someone's thought process play out. You get to watch where they see the pros and cons of their decision or the faults that could occur. And then you get to watch 'em navigate that, and then it succeeds and it's like, "hot dang, you did it." It's great. I love that. So that's probably something that makes me smile the most is when someone sees, their true potential being achieved, and they get to see it in the form of something as tangible as solving a problem. [00:31:22] Lindsey Dinneen: That is awesome. I love that so much. Oh my goodness. Well, this has been such an amazing conversation. I'm so thankful for you and for you being willing to share some of your time with me and with our listeners. So thank you so much for all the work you do, and thank you for being in the industry, being passionate about this industry and for being a change maker too, in the way that, you know, companies can operate and be successful. And we don't have to think about it just in terms of financial success, but we talk about it in terms of cultural success too. And so, I just really appreciate your perspective, so thank you for all the hard work you're doing to change lives for a better world. [00:32:02] Sarah Ptach: Thank you. Yeah, thank you, Lindsey. And likewise what you do. It's awesome to see you highlighting some of the stories in the industry and bringing together really good conversations like this. So thank you. [00:32:11] Lindsey Dinneen: Awesome. And we are so honored to be making a donation as a thank you for your time today to the Michael J. Fox Foundation, which is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today. So thank you for choosing that organization to support. Again, thank you so much and thank you also to our listeners for tuning in and if you're feeling as inspired as I am right now, I would love it if you would share this episode with a colleague or two and we'll catch you next time. [00:32:49] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.  

Das hast du über Isover noch nie gehört! Wir waren an der Holzmesse Basel 2025 zu Besuch bei Aurelien von Isover. Ein Schweizer Traditionsunternehmen, das seit 1937 innovative Dämmstoffe aus 80 % Recyclingglas entwickelt. Hier erfährst du, wie Nachhaltigkeit, Innovation und Schweizer Qualität in der Dämmstoffproduktion neu gedacht werden. Entdecke die Highlights direkt vom Messestand:  ISORIGID – die unbrennbare, begehbare Aufsparrendämmung für den Holzbau  Lanaé Produktlinie – Dämmung mit natürlichen, zuckerbasierten Bindemitteln  Neue Einblaswolle – leicht, effizient & ohne Setzungen  Akustiklösungen – spürbarer Schallschutz live im Akustiktunnel Hier gehts zur Isover Website: https://www.isover.ch/de  Hier geht's direkt zum Isover Youtube Kanal: https://www.youtube.com/@saint-gobainisoversasuisse5780  Wenn du im Holzbau, Dachbau, Innenausbau oder der Architektur tätig bist, darfst du dieses Video nicht verpassen.

In dieser Episode des Bauherren Podcast Schweiz tauchen wir tief in das Thema Vergabesitzungen und Preisverhandlungen ein – ein entscheidender Moment für jeden Unternehmer in der Bauwirtschaft. Du erfährst, wie du dich optimal auf die Vertragsunterzeichnung vorbereitest, welche typischen Bauleitertaktiken dich erwarten und wie du mit klugen Strategien mehr Gewinn erzielst, ohne unnötige Rabatte zu gewähren.  Marco teilt wertvolle Erfahrungen aus seiner Zeit als Bauleiter und zeigt auf, wo viele Unternehmer kurz vor der Unterschrift noch Fehler machen. Wir sprechen darüber, wie du deine Projektleiter besser einbeziehen kannst, um in Vergabegesprächen souverän aufzutreten. Zudem lernst du, welche alternativen Verhandlungsmöglichkeiten du nutzen kannst – von Schlechtwetterklauseln über Expressänderungen bis hin zu Projektoptimierungen. Diese Tipps helfen dir, wirtschaftlich erfolgreicher zu werden und langfristig stabil zu kalkulieren. Ein Muss für alle Unternehmer, Bauleiter und Projektleiter, die ihre Verhandlungskompetenz stärken und ihren Gewinn sichern wollen. Also: Setz dich an den Verhandlungstisch – aber diesmal mit der richtigen Strategie.

De fréiere grénge Minister François Bausch kritiséiert d'Ännerungen un der Streck vum séieren Tram an de Referendum zu Ierpeldeng iwwert d'Nordstadfusioun kënnt ëmmer méi no.

I am so excited to say that my guest on the GWA Podcast is one of the most exciting young painters working today, Eva Helene Pade. Born in Denmark in 1997, and based in Paris – where we are recording today – Pade is known for her rich and emotionally-charged, large-scale canvases populated with figures that morph in and out of abstraction. Often set in a dreamworld that can feel akin to being lost in a dance or state of unconsciousness, with fiery blazes and dark intense shadows, Pade's paintings exist in places beyond the realm of our world. They are full of ambiguity: as a viewer, you are unaware of whether they are in day or night, heaven or hell, if the figures are male or female, or set in an ancient world or contemporary life. Stylistically, Pade seems to borrow from a lineage of Northern European figurative artists, from Edvard Munch to Otto Dix, creating work akin surrealism or expressionism: artistic movements born out of a time of political tumult, yet exude freedom and liberation in their subject and handling of paint. This creates an interesting conversation about the state of the world vs then, and now. But she also goes further, imbuing her work with ancient stories and figures – such as Eve or maybe Ophelia – and stories, such as Stravinsky's The Rite of Spring, a ballet she was inspired by after seeing a performance choreographed by Pina Bausch, the influential German dancer. And like Bausch, Pade was drawn to rework the story from a female lens, which served as the foundation for her first ever museum show at Arken Denmark, opening just a year after she graduated from The Danish Royal Academy of Fine Arts in Copenhagen… Today, we meet Pade in her Paris studio on a very hot day ahead of a new exhibition of paintings that opens at Thaddeaus Ropac in London in October, and I can't wait to find out more… Exhibition: https://ropac.net/exhibitions/764-eva-helene-pade-sgelys/ -- THIS EPISODE IS GENEROUSLY SUPPORTED BY THE LEVETT COLLECTION: https://www.famm.com/en/ https://www.instagram.com/famm_mougins // https://www.merrellpublishers.com/9781858947037 Follow us: Katy Hessel: @thegreatwomenartists / @katy.hessel Sound editing by Nada Smiljanic Music by Ben Wetherfield

Are your eyes feeling dry or blurry during perimenopause or menopause? You're not alone—and this episode is for YOU.In this Episode of Functional Moms Podcast, we're joined by Dr. Neda Gioia, a nationally board-certified optometrist in both nutrition and functional medicine, to explore how hormonal changes impact women's eye health during midlife.Dr. Neda shares game-changing insights on:--Why dry eyes, blurry vision, and macular degeneration become more common in women over 40--How menopause hormones influence eye tissue and tear production--The best nutrients and dietary strategies to support your vision--Which eye symptoms shouldn't be ignored—and when to see an eye doctor--How to prep for your next eye exam for better outcomes--Whether blue light glasses really work--Why sun exposure, diet, and lifestyle directly impact your long-term eye healthLearn how to protect your eyes naturally—through food, lifestyle, and proactive care.RECOMMENDED EYE HEALTH SUPPLEMENTS (as mentioned in the episode, always check with your doctor first before adding supplements!):1- blink NutriTears by Bausch and Lomb for dry eye support2- Nordic Naturals- Pro-Omega 2000-Great for dry eye, macular support and overall eye health3-Metagenics: PhytoMulti Multivitamin - with or without iron. Great multivitamin that includes specific carotenoids called Lutein and Zeaxanthin which are foundational for eye health!4-Vitamin D/K- dosing dependent on needs-Helps reduce systemic inflammation which is linked to ocular inflammation!5-AREDS 2 formula for macular degeneration support- various brands- this includes the foundational evidence based formula (lutein, zeaxanthin, zinc, copper, vitamin C, and vitamin E)About Our Guest:Dr. Neda Gioia is the founder of Integrative Vision, a cutting-edge optometry practice blending clinical eye care with functional medicine. She's also the immediate past president of the Ocular Wellness and Nutrition Society.Key Takeaways from this episode:--Hormones affect your eyes more than you think--Dry eye symptoms: not just dryness—think tearing and blurriness too--Nutrients like omega-3s, lutein, zeaxanthin, and vitamin D are crucial for eye health--Cataracts, glaucoma, and AMD can be slowed with lifestyle strategies--Red light therapy is emerging as a promising tool for vision care--Mediterranean-style eating supports healthy aging and eye protectionConnect with Dr. Neda Gioia:Instagram: ⁠https://www.instagram.com/drnedagioia/⁠Website:https://integrativevision.com/https://www.youtube.com/@functionalmomspodcast

Wenn es erst in der Ausführung um Flucht- und Brandschutztüren geht, musst du mit Umplanungen und Korrekturen von funktionalen Mängeln rechnen. In dieser Folge erfährst du, wie du bereits in der Bedürfnisabklärung und Planung die wichtigsten Weichen stellst – und teure Fehler frühzeitig verhinderst. Türenspezialist Markus Egli (Geschäftsführer Metallbau Bühlmann AG) erklärt, worauf Bauleiter, Planer und Investoren von Anfang an achten müssen. Du bekommst praxisnahe Tipps zu kritischen Schnittstellen, erfährst, wie Zertifizierungen wie SIPIZ von Anfang an fachgerecht berücksichtigt werden – und warum die Öffnungsrichtung einer Tür kein banales Detail ist! Jetzt reinhören, wenn du Türen technisch durchdacht, normgerecht und langfristig betriebssicher planen willst! Mehr Infos über Metallbau Bühlmann: https://www.buehlmann-ag.ch/de    Weitere Podcastfolgen und Blogartikel findest du unter: www.marcofehr.ch/mehr    Abonniere, sonst gibt‘s Bauschäden ╔═╦╗╔╦╗╔═╦═╦╦╦╦╗╔═╗ ║╚╣║║║╚╣╚╣╔╣╔╣║╚╣═╣  ╠╗║╚╝║║╠╗║╚╣║║║║║═╣ ╚═╩══╩═╩═╩═╩╝╚╩═╩═╝   Für weitere Fragen kontaktiere bitte diese Adresse: redaktion@marcofehr.ch --------------------------------------------------------------- Folge mir auf diesen Kanälen für mehr Bauqualität und Kosteneinsparung • LinkedIn - https://www.linkedin.com/in/marco-fehr/  • Facebook -  https://www.facebook.com/marco.fehr.12  • Twitter - https://twitter.com/MarcoFehr_  • Tiktok - https://www.tiktok.com/@bauherren_podcastschweiz  • Instagram - https://www.instagram.com/marco.fehr_/  • Blog - https://marcofehr.ch/baublog/  • Spotify - https://open.spotify.com/show/2XPzukLLm2EGVxpVwMoiys  • YouTube - https://www.youtube.com/@bauherrenpodcastschweiz  • iTunes - https://podcasts.apple.com/ch/podcast/bauherren-podcast-schweiz/id1485359745  • LinkedIn Bauexperten Gruppe - https://www.linkedin.com/groups/13832518/  • Marketing-Akademie für Bauexperten - https://baufachwissen-akademie.ch/course/baufachwissen-marketing 

In dieser Episode sprechen die Umweltexpertinnen Stephanie Ertl und Maria Leidemann über die Vorteile und Möglichkeiten der Fassadenbegrünung. Sie erhalten wertvolle Einblicke und praxisnahe Tipps zur sicheren Begrünung ohne Bauschäden. Die Anwendungsmöglichkeiten sind vielfältig. Erfahren Sie mehr über attraktive Kletterpflanzen und dazu passende Rankhilfen. 

Als Marketinghead in der Baubranche kennst du das Problem: Du bist darauf angewiesen, dass dir Projektleiter spannende Inhalte von den Baustellen liefern – doch oft erfährst du zu spät davon oder bekommst gar keine Updates. Das führt dazu, dass dir wertvoller Content für Social Media, Website, Newsletter oder Print verloren geht. Genau hier setze ich in dieser Podcastfolge an. Ich zeige dir 3 einfache Strategien, wie du es schaffst, dauerhaft hochwertigen Content aus den Projekten deiner Firma zu sichern – direkt von den Projektleitern. Dabei erkläre ich dir, warum ein monatlicher Baustellenbesuch mit einem Projektleiter Gold wert ist. Du erfährst auch, wie du es den Projektleitern mit smarten Erinnerungen und einfachen Prozessen so leicht wie möglich machst. Und ich zeige dir, warum eine enge Verbindung zwischen Marketing und den Projektsitzungen ein absoluter Gamechanger ist. Am Ende verrate ich dir noch, weshalb es Sinn macht, mit einem externen Content-Marketing-Spezialisten zusammenzuarbeiten, der die Sprache der Bauleiter spricht und deine Zielgruppe versteht. So wird dein Content relevanter, spannender und du gewinnst Reichweite, neue Kunden und Bewerber.

Ken Banta, founder and CEO of the Vanguard Network, is a recognized expert in leadership and organizational change. With a rich background as a journalist—covering pivotal events like the Eastern European revolutions for Time magazine—Ken transitioned into corporate leadership, helping guide major turnarounds at companies such as Pharmacia and Bausch & Lomb. His latest book, Seeing Around Corners, gathers lessons from top leaders and is designed to inspire everyone, from emerging professionals to global executives. Ken's perspective on leadership is shaped by witnessing ordinary people drive extraordinary change, often guided by unexpected leaders like Vaclav Havel. These experiences reinforced his belief that leadership isn't just for those at the top; anyone, regardless of background or title, can play a vital role. True leaders are consistent in their purpose, adaptable, and agile—qualities that matter as much in everyday life as in the boardroom. Ken's key takeaway is simple: leadership is for everyone. Whether you're leading a team or contributing as an individual, you can make an impact by being clear on your purpose, staying flexible in your approach, and staying connected to those around you. Embrace your own ability to lead and remember—often, the most lasting change comes from ordinary people stepping up in extraordinary ways.

Eine kurze Nacht im Hotelzimmer, geweckt vom ersten Sonnenstrahl – weil die Vorhänge nicht abdunkeln? Das muss nicht sein! Ob im Hotel, im Altersheim, im Büro oder zu Hause: Wer sich mit den wichtigsten Vorhang-Fragen frühzeitig auseinandersetzt, hat weniger Ärger bei der Montage und mehr Komfort im Alltag. In dieser Folge erfährst du von Patrick Schwärzler, dem Inhaber von vorhangmacher.ch, worauf es ankommt: von der Stoffwahl über korrekte Schienenmontage bis zur professionellen Ausschreibung. Patrick besitzt langjährige Erfahrung und teilt sein Wissen mit viel Praxisnähe und Leidenschaft. Du hörst unter anderem: Welche 3 wichtigen Angaben in der Vorhang-Ausschreibung häufig fehlen Weshalb der Vorhangmacher unbedingt Aufputz-Schienen empfiehlt Wie ein kleines Etikett am Vorhang Hunderte Franken sparen kann Patrick hat zudem ein exklusives Geschenk für dich – deshalb: unbedingt reinhören!   Mehr Infos zum Unternehmen: https://vorhangmacher.ch/    Weitere Podcastfolgen und Blogartikel findest du unter: www.marcofehr.ch/mehr    Abonniere, sonst gibt‘s Bauschäden ╔═╦╗╔╦╗╔═╦═╦╦╦╦╗╔═╗ ║╚╣║║║╚╣╚╣╔╣╔╣║╚╣═╣  ╠╗║╚╝║║╠╗║╚╣║║║║║═╣ ╚═╩══╩═╩═╩═╩╝╚╩═╩═╝   Für weitere Fragen kontaktiere bitte diese Adresse: redaktion@marcofehr.ch --------------------------------------------------------------- Folge mir auf diesen Kanälen für mehr Bauqualität und Kosteneinsparung • LinkedIn - https://www.linkedin.com/in/marco-fehr/  • Facebook -  https://www.facebook.com/marco.fehr.12  • Twitter - https://twitter.com/MarcoFehr_  • Tiktok - https://www.tiktok.com/@bauherren_podcastschweiz  • Instagram - https://www.instagram.com/marco.fehr_/  • Blog - https://marcofehr.ch/baublog/  • Spotify - https://open.spotify.com/show/2XPzukLLm2EGVxpVwMoiys  • YouTube - https://www.youtube.com/@bauherrenpodcastschweiz  • iTunes - https://podcasts.apple.com/ch/podcast/bauherren-podcast-schweiz/id1485359745  • LinkedIn Bauexperten Gruppe - https://www.linkedin.com/groups/13832518/  • Marketing-Akademie für Bauexperten - https://baufachwissen-akademie.ch/course/baufachwissen-marketing  

Viele Handwerker wagen den Schritt in die Selbstständigkeit, doch schon bald stellt sich die grosse Frage: Wie gewinne ich Kunden, die meine Arbeit schätzen und bereit sind, dafür auch den richtigen Preis zu zahlen?  Ein häufiger Fehler ist es, über den Preis einzusteigen und dadurch langfristig Verluste zu riskieren. Stattdessen braucht es eine klare Strategie, um Sichtbarkeit zu erlangen, Vertrauen aufzubauen und sich als Experte zu positionieren. In dieser Episode sprechen wir über die typischen Stolpersteine beim Start eines Handwerksunternehmens und wie du diese vermeidest. Wir zeigen dir, wie Spezialisierung dir hilft, die richtigen Kunden anzusprechen, warum es so wichtig ist, selbstbewusst zu deinen Preisen zu stehen und wie digitale Kanäle dich von Mitbewerbern abheben.  Zusätzlich erfährst du, wie ein cleverer Lead-Magnet dir neue Kundenkontakte bringt und warum hochwertige Arbeit immer die beste Grundlage für nachhaltigen Erfolg ist. Mit praxisnahen Beispielen und direkt umsetzbaren Tipps erhältst du hier einen klaren Fahrplan für dein Handwerksbusiness. Mein Geschenk an dich: Nutze mein Fachwissen als Bauleiter und Marketingexperte. Zusammen können wir dein Expertenwissen sichtbar machen und deine Wunschkunden werden auf dich aufmerksam. Schreib mir jetzt eine Mail an: marco@marcofehr.ch und wir werden in einem kostenfreien Kennenlerngespräch deine perfekte Marketingstrategie erarbeiten. Gruss Marco    

D'Wunnengsnout zu Lëtzebuerg ass ee richtege Brandbeschleuneger vun der Onzefriddenheet. Si gräift mëttlerweil bis déif an d'Mëttelschicht eran.

D'Wunnengsnout zu Lëtzebuerg ass ee richtege Brandbeschleuneger vun der Onzefriddenheet. Si gräift mëttlerweil bis déif an d'Mëttelschicht eran.

In this episode of the Interventional Glaucoma Podcast, Prof. Verena Prokosch and Ms. Nishani Amerasinghe discuss the integration of minimally invasive glaucoma surgery (MIGS) into routine cataract surgery. They focus on how laser-based trabecular procedures can be efficiently combined with phacoemulsification to improve outcomes for glaucoma patients.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.  ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.  Find out more about ELIOS : http://bit.ly/4lWBJZ1

Want to Start or Grow a Successful Business? Schedule a FREE 13-Point Assessment with Clay Clark Today At: www.ThrivetimeShow.com   Join Clay Clark's Thrivetime Show Business Workshop!!! Learn Branding, Marketing, SEO, Sales, Workflow Design, Accounting & More. **Request Tickets & See Testimonials At: www.ThrivetimeShow.com  **Request Tickets Via Text At (918) 851-0102   See the Thousands of Success Stories and Millionaires That Clay Clark Has Helped to Produce HERE: https://www.thrivetimeshow.com/testimonials/ Download A Millionaire's Guide to Become Sustainably Rich: A Step-by-Step Guide to Become a Successful Money-Generating and Time-Freedom Creating Business HERE: www.ThrivetimeShow.com/Millionaire   See Thousands of Case Studies Today HERE: www.thrivetimeshow.com/does-it-work/  

Bausch, Joe www.deutschlandfunkkultur.de, Fazit

Want to Start or Grow a Successful Business? Schedule a FREE 13-Point Assessment with Clay Clark Today At: www.ThrivetimeShow.com   Join Clay Clark's Thrivetime Show Business Workshop!!! Learn Branding, Marketing, SEO, Sales, Workflow Design, Accounting & More. **Request Tickets & See Testimonials At: www.ThrivetimeShow.com  **Request Tickets Via Text At (918) 851-0102   See the Thousands of Success Stories and Millionaires That Clay Clark Has Helped to Produce HERE: https://www.thrivetimeshow.com/testimonials/ Download A Millionaire's Guide to Become Sustainably Rich: A Step-by-Step Guide to Become a Successful Money-Generating and Time-Freedom Creating Business HERE: www.ThrivetimeShow.com/Millionaire   See Thousands of Case Studies Today HERE: www.thrivetimeshow.com/does-it-work/  

An acknowledged master of the short story form, Richard Bausch's work has appeared in The Atlantic Monthly, Esquire, Gentleman's Quarterly, Harper's, The Missouri Review, The New Yorker, Narrative, New Letters, Playboy, Ploughshares, and The Southern Review, and his stories have been widely anthologized, including The Best American Short Stories, O. Henry Prize Stories, and Pushcart Prize Stories, among others. He is the author of thirteen novels and ten collections of stories, including his new collection, The Fate of Others. Richard joins Barbara to talk about his path to writing fiction, various stories in the collection as well as titling stories, arranging stories in the book, the difference between writing novels and stories, and so much more. For more information on Writers on Writing and to become a supporter, visit our Patreon page. For a one-time donation, visit Ko-fi. You can find hundreds of past interviews on our website. You can help out the show and indie bookstores by buying books at our bookstore on bookshop.org. It's stocked with titles by our guest authors, as well as our personal favorites. And on Spotify, you'll find an album's worth of typewriter music like what you hear on the show. It's perfect for writing. Look for the artist, Just My Type. Email the show at writersonwritingpodcast@gmail.com. We love to hear from our listeners! (Recorded on June 27, 2025) Host: Barbara DeMarco-Barrett Host: Marrie Stone Music: Travis Barrett (Stream his music on Spotify, Apple Music, Etc.)

Send us a textThis week, we catch up with the great Mike Bausch. He brings such knowledge, energy and leadership to the pizza community. Mike now has 12 restaurants in the Tulsa, Oklahoma area, including Andolini's Pizzeria and a newer fine dining spot, Prossimo Ristorante. He's an Oklahoma's Small Business Entrepreneur of the Year, No. 1 Amazon best-selling author, Tulsa's Restauranteur of the Year and a two-time Guinness World Record holder. You can find him each month in the pages of Pizza Today Magazine in his Column “Mike's Monthly Tip”, where he shares advice and experiences with fellow pizzeria operators.In a time of uncertainty for many restaurants, Andolini's is having a banner year. We talk about why and how his restaurants are finding success. Mike always shares candidly his failures and successes to help other restaurant owners. We talk about what restaurants are currently up against.  If you need a business pep talk, this is the episode for you. Mike drops a lot of wisdom in a short podcast.Learn more about Andolini's Pizzeria at https://andopizza.com/ and follow Mike Bausch on Instagram at https://www.instagram.com/mikeybausch/Check out his latest Mike's Monthly Tip “Weather the Storm, Build the Bond” at https://pizzatoday.com/topics/operations/mikes-monthly-tip-weather-the-storm-build-the-bond/

In this episode, host Mitch Robbins welcomes Terry Van Epps, Global Head of Talent Acquisition at Sirtex Medical, a commercial-stage medtech company focused on minimally invasive cancer therapies. With over 20 years of experience leading talent acquisition efforts at global organizations—including Xerox, Bausch & Lomb, Panasonic, and growth-stage biotech firms—Terry brings a grounded, systems-minded approach to transforming hiring functions from the inside out.Terry shares how he approached his first months at Sirtex, where he discovered $1.3M in unchecked agency spend despite having an internal TA team—and what he did next to fix it.They also unpack:How Terry rebuilt credibility with hiring managers who had gone rogueHis clear criteria for choosing (and keeping) agency partnersHow Sirtex slashed agency fees by 90% in 2 years without slowing down hiringWhy the best TA leaders still “work the desk”—and what that teachesA grounded take on AI in recruiting—what's hype, what's helpfulPlus, his take on the one thing too many teams still overlook: tune in to find out!.Whether you lead a TA function or support one, this episode is packed with takeaways on how to be a better partner, a smarter operator, and a more trusted hiring voice.

In this episode, host Gok Ratnarajan is joined by Dr. Ana Miguel, Dr. Karl Mercieca, and Dr. Jose Belda to explore whether patients truly experience greater happiness following glaucoma surgery. Through anonymized case studies and real-world examples, the panel delves into how an interventional glaucoma approach can impact patient quality of life. Together, they reflect on patient expectations and outcomes, sharing personal experiences to provide a balanced and insightful discussion on the patient perspective in glaucoma care.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany.  ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices. 

Hello dear friends,What does it mean to be a “superwoman” in music—then and now? In this episode, we travel from the finely tuned mechanics of 19th-century fortepianos to the bold visions of contemporary curators as we explore Superwomen—a newly launched festival in Basel by pianist and researcher Laura Granero and piano restorer Sebastian Bausch, the duo behind Klavieratelier Mignon 1904.Together, we unfold a multi-sensory conversation, from salon culture to technological time capsules. Expect to meet the dazzling Fanny Davies—not only a pianist of Schumann's inner circle but also a visual artist and chronicler of her musical world (hear her play Davidsbündlertänze here). We'll also discuss diva, entrepreneur, and Rossini's first wife Isabella Colbran (profile), whose fortune helped fund the composer's comfort.And yes, there were bread sculptures. The 19th-century salon scene was full of unexpected flourishes—often led by female artists who shaped cultural trends far beyond the concert hall. We dive into the curious tale of musical baking, the gender politics of programming, and the enduring influence of the salonnières.Adding a present-day sparkle, we taste a bottle from Cava Hispania and raise a glass to Darina's second podcast, Why White Wine, celebrating the role of wine in collaboration and storytelling.With fortepiano improvisations on John Field's Nocturne No. 5 (performed by Laura Granero), reflections on feminist agency in curation, and a touch of irony, this episode invites you to rethink tradition with intelligence, warmth, and a generous pour.

Richard Bausch discusses his latest story collection, The Fate of Others. This may be the author's 24th book, but it is a fresh, powerful collection of stories for today's world with all its resonances of loss and isolation—but also of hope.

Mike Bausch is an industry leader whose restaurant, Andolini's Pizzeria, is a top ten pizzeria in the US, as named by Trip Advisor, BuzzFeed, CNN and USA Today. Andolini's began in 2005 and has grown to five pizzerias, two gelaterias, two food-hall concepts, a food truck, and a fine dining restaurant by 2020. He's a World Pizza Champion, a Guinness Book world record holder, and a writer for Pizza Today, and the author of Unsliced: How to Stay Whole in the Pizzeria Business. Mike was previously on the show for episode 772. Do YOU want to work with Mike? Click here -> https://getunsliced.com/unstoppable This workshop covers Mike's "3 Steps to Systemize Your Ownership." Workshops can be found every Thursday in the Restaurant Unstoppable podcast feed or on YouTube. Most have a visual component, so consider watching the video version here. Join the RUNetwork to take part in workshops and ask the experts YOUR questions! Join the Restaurant Unstoppable Network TODAY! Restaurant Unstoppable - EVOLVE! - Eric of Restaurant Unstoppable is now taking consultation and coaching calls! Book a consultation today! Schedule your call to become UNSTOPPABLE! Check out the website for more details: https://www.restaurantunstoppable.com/evolve Today's sponsors: Franchise Law Solutions - Thinking about franchising your restaurant? Success doesn't have to mean 100 units overnight. With the right plan, you can build a profitable, local or regional franchise brand. The team at Internicola Law Firm — franchise lawyers and franchise development experts — will show you how.  Visit www.franchiselawsolutions.com. Meez: Are you a chef, owner, operator, or manage recipes in professional kitchens? meez is built just for you. Organize, share, prep, and scale recipes like never before. Plus, engineer your menu in real-time and get accurate food costs. Sign up for free today and get 2 FREE months of invoice processing as a listener of the Restaurant Unstoppable Podcast. Visit getmeez.com/unstoppable to learn more. Restaurant Systems Pro - Join the 60-day Restaurant Systems Pro FREE TRAINING. This is something that has never been done before. This 60-day event is at no cost to you, but it is not for everyone. Fred Langley, CEO of Restaurant Systems Pro, will lead a group of restaurateurs through the Restaurant Systems Pro software and set up the systems for your restaurant. During the 60 days, Fred will walk you through the Restaurant Systems Pro Process and help you crush the following goals: Recipe Costing Cards; Guidance in your books for accounting; Cash controls; Sales Forecasting(With Accuracy); Checklists; Budgeting for the entire year; Scheduling for profit; More butts in seats and more… Click Here to learn more.  Let's make 2025 the year your restaurant thrives. Today's guest recommends:  Ovation Asana 7Shifts Loom Cling App Wisely Guest contact info:  https://getunsliced.com/ Thanks for listening! Rate the podcast, subscribe, and share!  We are on Youtube: @RestaurantUnstoppable

While they differ in size of revenue, U.S. CPG Growth Leaders all found innovative ways to connect with fragmented consumer communities using a range of growth levers. Sally Lyons Wyatt and Cara Loeys dive into the strategies that leading CPG companies deployed to achieve healthy growth in 2024, including the Five Cs of Success: community connections, comprehensive value, catering to multi-pronged wellness, collaborative growth, and company culture.   Key takeaways: Community connections: King Arthur Baking leaned on the experiences of consumers during COVID-19 to build a thriving baking community. This approach highlights the importance of engaging with consumers across different touchpoints and supporting them through innovative products and resources. Comprehensive value: Companies like Lifeway and Bausch & Lomb offer multi-functional products that provide a wide range of benefits. This strategy emphasizes the importance of delivering value that goes beyond price, enhancing convenience, experience, and well-being. Collaborative growth: Good Culture and Daisy Brand are reimagining their products and partnering with influencers to engage younger consumers. Innovative use of AI: The Coca-Cola Co. and e.l.f. Beauty are at the forefront of experimenting with AI to enhance productivity, efficiency, and consumer engagement. From AI-generated commercials to social media bots, these innovative approaches are revolutionizing how companies connect with their audience. Direct-to-consumer engagement: Company collaborations are resulting in successful, out-of-the-box solutions, many of which leverage digital sales and online promotional events to create buzz and engage loyal consumers.

Robert Edward Grant was formerly CEO and President of Bausch and Lomb Surgical in June of 2010. Prior to this, he led Allergan Medical as President from 2006 to 2010.Robert has served on several corporate boards. He served as an independent Board Director at Myoscience, Inc., Acufocus, Inc. and ReShape Medical, Inc and presently serves on the boards of ALPHAEON Corporation and Zelegent, Inc. Additionally, he serves as Chairman and Founder of Crown Sterling Ltd, a Fintech/Cryptography subsidiary of Strathspey Crown LLC.Additionally, he serves or has served on the boards of the following university and charitable organizations: The Schmid College of Chapman University, the University of California, Irvine (UCI) CEO Roundtable Steering Committee, The School of Law at UCI, The Henry Samueli School of Engineering, OCTANe (501-C3 non-profit entity) an economic development corporation for technology companies in Orange County, California where he served as Chairman of the Board of Directors, and the Young President's Organization (YPO/WPO) Southern California Chapter where he currently serves as Chairman of the Board.An accomplished sculptor, artist, and musician, Robert Grant additionally holds several patents and various intellectual property in the fields of DNA and phenotypic expression, human cybernetic implantology, biophotonics, and electromagnetism.He has multiple publications in unified mathematics and physics related to his discoveries of quasi-prime numbers (a new classification for prime numbers), the world's first predictive algorithm determining infinite prime numbers, and a unification wave-based theory connecting and correlating fundamental mathematical constants such as Pi, Euler, Alpha, Gamma and Phi.Robert holds a BA from Brigham Young University and an MBA (graduating with Honors) from Thunderbird, The American Graduate School of International Management. Additionally, he has attended the President's Seminar at Harvard Business School ('09-'16).He has lived and worked in nine countries and speaks Japanese, French, Korean and German fluently.In what he considers his finest achievement and crown jewels, Robert is father to three beautiful children and lives with his wife and two youngest, in Orange County, CA.Please enjoy my conversation with Robert Edward Grant.Become a supporter of this podcast: https://www.spreaker.com/podcast/next-level-soul-podcast-with-alex-ferrari--4858435/support.

Heute wartet eine Folge auf Euch, in der es um eure Gesundheit beim Bauen geht. Denn wir sprechen über ein Thema, das viel zu oft übersehen wird: Schadstoffe, Schimmel & Schädlinge. Zu Gast ist heute Esther Karl – Bauingenieurin, geprüfte Baubiologin und bekannt durch ihren Instagram-Kanal Casa Karoni, wo sie über gesundes Bauen aufklärt. Esther weiß aus eigener Erfahrung, worauf man achten sollte, wenn man sich den Traum vom Eigenheim erfüllt – vor allem, wenn man langfristig gesund wohnen möchte. In der heutigen Folge erfährst Du: • Warum es beim Thema Schadstoffe einen großen Unterschied macht, in welchem Baujahr die Immobilie gebaut wurde • Welche Baumaterialien oft mit Schadstoffen belastet sind – und wo überall Schadstoffe drin sein können. Kleiner Spoiler: Eigentlich fast überall. • Worauf ihr besonders achten solltet, wenn ihr in Eigenleistung saniert und euch eure Gesundheit am Herzen liegt. • Wie ihr Schimmel richtig erkennt und warum Überstreichen nicht die Lösung ist • Welche Schädlinge Hinweise auf größere Bauschäden geben können – und warum Silberfische manchmal die wahren Spürnasen sind. • Und warum ihr nie eine Immobilie kaufen solltet, ohne vorher die Raumluft prüfen zu lassen oder zumindest jemanden vom Fach mit zur Besichtigung zu nehmen. Also heute müssen alle die Ohren spitzen, die gerade viel Besichtigungen – diese Folge ist ein wertvoller Überblick über Schadstoffe, Schimmel und Schädlinge. Und jetzt viel Spaß mit Ester. Los geht's!

Joe Pardavila sits down with Merle Symes, author of The Innovation Edge: How Large Companies Lose It and How to Get It Back, to explore the challenges and nuances of fostering innovation in established organizations.Merle breaks down the critical differences between incremental and strategic innovation, explaining why traditional project management methods often fail when applied to groundbreaking ideas. The conversation delves into the "S-Curve Paradox," where companies at their peak success are most vulnerable to disruption, and the concept of "intelligent failure"—how to fail purposefully and learn from setbacks without stifling creativity.Joe and Merle also discuss the cultural barriers to innovation, including short-termism, the "check-the-box" mentality, and the need for leadership to embrace an "ambidextrous" approach—balancing immediate goals with long-term vision. Through real-world examples like Kodak, Blockbuster, and Intel, they highlight the consequences of resting on past successes and missing emerging opportunities.Touching on the role of AI and the importance of organizational mindset, this episode offers actionable insights for leaders aiming to reignite innovation in their teams. Whether you're navigating corporate inertia or looking to build a culture of continuous reinvention, Merle's expertise provides a roadmap for staying ahead in an ever-evolving business landscape.Merle Symes works with senior management teams to help them realize their aspirations through agile strategy, high-impact innovation, and business performance. He has assisted senior management teams in organizations ranging from Fortune 500 companies to early-stage ventures.Mr. Symes has developed a number of leading-edge principles and tools for enhancing business success. It includes a process for creating Innovation by Design® in strategically targeted areas, project management methods and active risk management tools for managing high return/higher risk innovation, and business performance initiatives and guidelines for helping management teams develop a more entrepreneurial and innovative culture.In his 50-year career, Mr. Symes has held a number of executive positions and he brings real-world knowledge and experience to leading-edge methods and practices. Most recently he has served as CEO of the tech venture, Graematter. His previous positions include President of Ulrich Medical, a U.S. subsidiary of a German medical device company. Prior to that he held the position of Vice President, External Technology for Bausch & Lomb where his organization established a process for locating and acquiring external technology that was recognized by the Corporate Executive Board as being one of the top five best practices, as identified in their research of major companies.Mr. Symes has served in executive positions in both the U.S. and Europe, including turnaround situations. Prior to Bausch & Lomb, he held positions in Wyeth (now part of Pfizer), Monsanto and Dupont. He regularly advises boards of directors and has held board director positions on both public and privately held companies as well as university and charitable organizations. He is affiliated with and serves as a Managing Director of The Walden Group, a boutique New York investment bank specializing in M&A in the medical industry.Mr. Symes has an MBA from the Wharton Graduate School and a B.S. in Chemical Engineering from the South Dakota School of Mines & Technology where he has been honored with their Distinguished Alumni Award and serves as Chairman of their University Advisory Board.

Wim Wenders had planned for years with German Neo-expressionist choreographer Pina Bausch to make a film of her work, but Wenders didn't know how he could do it justice. Then he saw U2 3D (2008) and knew that digital 3D was the technology he needed. Unfortunately, as technology caught up to Wenders' vision, Bausch passed away, and Pina (2011) morphed from just a document of her work into a tribute from Wenders and Bausch's dance troupe. What they create together is an overwhelming piece of art.

durée : 01:25:57 - Les Nuits de France Culture - par : Albane Penaranda - "Nuits magnétiques", Chantal Aubry faisait le voyage en Allemagne pour rencontrer les danseurs qui travaillaient alors aux côtés de Pina Bausch au Tanztheater de Wuppertal. Précieux témoignages sur le travail avec la grande chorégraphe qui donnait elle-même un court entretien à la fin de l'émission. - réalisation : Virginie Mourthé - invités : Pina Bausch Chorégraphe et danseuse allemande; Dominique Mercy

Mylan Pharmaceuticals Inc. v. Bausch Health Ireland Ltd.

Many of the new dets like Carnivore and Ketogenic diets are prematurely aging the body. However simply adding some fruit and not staying in ketosis all the time will benefit your health. Intermittent fasting is causing the hair follicle stem cells to die off and ultimately causing hair loss. So, you must think twice about fasting and utilizing a very low carb diet for anti-aging. The right carbs are very good for all aspects of your health. The Lange Survival Diet takes all of this into consideration. Lange Survival Diet is developed to help us survive into our really old age. It has taken out all the potential harmful aspects of foods like lectins, gluten, fodmaps, phytic acid, oxalates etc,,,, Lange Survival Diet has a list of "safe " foods. Glp-1 receptor drugs are not without potential complications. GLP1 drugs have been implicated in many negative side effects like; ischemic optic neuropathy, sarcopenia, osteoporosis, stomach paralysis and much more. Anyone taking a GLP1 drug needs to be monitored by their physician carefully. Dr Lange expands on the health benefits of Fortifeye Rejuvenate with a caller that has an amazing testimonial about her health since starting Fortifeye Rejuvenate less than a year ago. He also discusses osteopenia and vitamin d with callers and natural ways to help. Another caller wants some information about ocular hypertension. Dr Lange states to follow his docs advice and gives some solid nutritional and lifestyle changes to make. He does discuss the all new Fortifeye Eye Pressure and Neuro Cognitive support supplement. Roger P Shullman was a guest on the show and they both discuss the powers of the correct form of omega 3 fish oil and also talk about Bausch and Lomb Infuse daily contact lenses. They also discuss some new natural sweeteners they are testing for Fortifeye Fit Pro. New Vegan Super Protein build muscle while losing fat. Dr Lange talks about the new Fortifeye Vegan Super Protein and the potential health benefits obtained from this new formula. He also does a segment about getting more fruits and vegetables and boosting immunity and athletic performance by using Fortifeye Next Gen Organic Blue Green Superfood. Dr Michael Lange is among a select group of optometric physicians that are considered aging experts, and he is involved in the development of supplements that are redefining aging. His talk shows are geared toward nutritional wellness of the eyes and entire body. #theagingexperts #proteinsupplement #redefiningaging #wheyprotein #successfulaging #wheypowder #nutritionalwellness #anrtiaging #glp1 #glp1forweightloss #glp1medication #glp1community #vegandiet #veganproteinpowder #vegansuperprotein #veganprotein #Fortifeye #omega3 #rTGomega3 #TGomega3 #omega3fishoil #diet #aginggracefully #agingpreventionSupport the show: https://www.drmichaellange.com/category/ask-the-doctor/See omnystudio.com/listener for privacy information.

This week on the Build a Vibrant Culture Podcast, Nicole interviews Willie Pietersen. Willie specializes in strategy and the leadership of change, and his methods and ideas-especially strategic learning-are widely applied within the Columbia's executive education programs, and also in numerous corporations. He has served as a teacher and advisor to many global companies, including Aviva, Bausch & Lomb and Boeing.  Willie is the author of three books and numerous articles, and in this episode we'll be looking at his latest book: Leadership - The Inside Story: Time Tested Prescriptions for Those Who Seek to Lead.In this episode, Willie and Nicole talk about: [00:06:38] How Nelson Mandela's personal values led to unprecedented leadership[00:24:29] How philosophy helps us think more clearly and do better work[00:27:52] Four Biases and how being aware of them will help our decision-makingWe are so grateful to Willie for sharing his wealth of knowledge and passion for leadership, strategic learning, and so much more! His insights are sure to inspire professionals and leaders of all kinds to BUILD A Vibrant Culture.Get Willie's book today! https://a.co/d/gHnY1mIWant to know more about Willie?Willie's website: https://williepietersen.com/LinkedIn - https://www.linkedin.com/in/willie-pietersen-286b149/X (formerly Twitter) - https://x.com/WillPietersenFacebook - https://www.facebook.com/williepietersenauthor/Instagram - https://www.instagram.com/williepietersen1/YouTube - https://www.youtube.com/@WilliePietersenAuthorOther books mentioned on this episode:The Fifth Discipline by Peter M. Senge: https://a.co/d/iQLJANLHow Philosophy Can Save Your Life by Marietta McCarty: https://a.co/d/gkpai4vMemory by Hermann Ebbinghaus: https://a.co/d/coxeltfSmart Leaders, Smarter Teams by Roger M. Schwarz: https://a.co/d/ivfJILfThinking, Fast and Slow by Daniel Kahneman: https://a.co/d/1GTZjphThe Origin of Species by Charles Darwin: https://a.co/d/f0fIeXnDon't forget to like, comment, and subscribe to the Build a Vibrant Culture podcast for more insights on creating thriving workplaces!

Daniel Cho has over 29 years of experience in the healthcare industry, currently serving as the Senior Director of Global Pricing at Philips Healthcare. With a background in sales, product management, and pricing strategy, Daniel has a unique perspective on how to effectively communicate value to customers and drive profitability. In this episode, Daniel shares his journey into pricing and the critical importance of understanding the value your product delivers to customers. He emphasizes that pricing should not just be about features but about the economic, operational, emotional, clinical, and societal value that resonates with different stakeholders. Through real-world examples, Daniel illustrates how a well-structured pricing strategy can lead to stronger, more profitable relationships.   Why you have to check out today's podcast: Discover the five key value drivers that can transform your pricing strategy and enhance customer relationships. Learn how to effectively communicate value to different stakeholders within a healthcare organization, from CFOs to clinical staff. Gain insights into structuring contracts and pricing metrics that align with customer needs and perceptions of value.   “Resist on the discount as much as possible. Look for every other ways to solve it rather than the discount. The discount should always be a last resort and not the first thing you want to deliver or give.” – Daniel Cho   Topics Covered: 02:33 - Daniel's journey into pricing 03:23 - The power of pricing strategy, using segmentation and perceived value to differentiate identical products for distinct markets 06:58 -  How two identical products can be integrated differently with existing pricing ecosystems 07:57 - Leveraging his expertise in data analysis to establish Philips' first pricing department 12:11 - Initiating a value-based approach at Philips to create, price, and articulate value 14:22 - Defining value and discussing the 5 key value drivers in a health organization 18:03 - Tailoring value propositions and demonstrating how those four other value streams ultimately lead to financial and strategic benefits 25:22 - An effective sales training Daniel created that teaches salespeople to tailor value-based pitches to different stakeholders' priorities 31:27 - Daniel's best pricing advice   Key Takeaways: “We cannot continue to sell features and benefits, we have to go and sell value.” - Daniel Cho “If the product is not value-based, you can't ask the salespeople to sell value because you have to start from the product that actually deliver and generate value. So, we started from the product managers.” - Daniel Cho “The first one is economic value. Very simple. Help me to make more revenue or help me to save costs so I have an economic benefit.” - Daniel Cho “The next value is the emotional value. How can we create a better experience for the patients and also their own staff so the staff don't get burnout.” - Daniel Cho “Financial value, although as strong as it is, doesn't resonate with everyone.” - Daniel Cho “Stop giving discounts for free. Always get something back from the customer.” - Daniel Cho   People/Resources Mentioned: Philips Healthcare: https://www.philips.com/ Apple Watch Launch: https://www.apple.com/ Bausch and Lomb Contact Lens Case: https://www.bausch.com/   Connect with Daniel Cho: LinkedIn: https://www.linkedin.com/in/danielkkcho/   Connect with Mark Stiving: LinkedIn: https://www.linkedin.com/in/stiving/ Email: mark@impactpricing.com